Forecast Sales for Human and Animal Health
ClearikonFLEX™ is designed for frontline healthcare professionals such as in hospitals, clinics, and home health organizations. Our 2026 commercialization strategy will leverage strategic partners to expand sales and distribution channels to hospital, home health, military, and retail customers.
We have also develped ClearikonFLEX™ products for Animal Health. We currently sell equine bandages, disinfection, and topical wound products. Our products are engineered for professional use by veterinarians across clinical, hospital, and farm settings. Clearikon's 2026 market strategy is to support our veterinay sales represeative to build our business with high-volume ecomerce sales to retail and veterinary customers.
•Medical Device Contract Manufacturing - Ongoing
•Simplified Class 1 Bandage FDA Notification Q2-2026
•CMS Reimbursement application July 1 -2026
•Sales Release - Q3-2026
•Distributor sales agreements with hospitals, clinics, and home healthcare Q3-2026
•Medical Device Contract Manufacturing - Ongoing
•Veterinary sales agreements Q2-2026
Raise $2M - Q2 2026
Shareholders include founders, friends, and a veterinarian
Current shareholders own common stock
Clear Care Products, Inc.
Delaware C Corporation - Incorporated October 2016